Cardiology Headline News

Withings Health Solutions announced its novel cellular BP monitor received FDA clearance to measure BP and pulse rate in adults with arm circumferences of 22 cm to 42 cm or 40 cm to 52 cm.

Individuals with diabetes who were hospitalized for non-ST elevation myocardial infarction had significantly higher risk for long-term mortality compared with individuals without diabetes, according to new research.

According to a new report from the National Academies of Sciences, Engineering, and Medicine, or NASEM, moderate alcohol consumption may lower the risk for death from all causes and CVD.

Improved screening for elevated lipoprotein(a) levels among all adults may improve CVD risk assessment and outcomes, especially with multiple Lp(a)-lowering therapies currently in the research pipeline, a speaker reported.

The FDA has approved Zepbound (tirzepatide), a prescription medicine for adults with moderate to severe obstructive sleep apnea and obesity, Eli Lilly and Company announced ina press release.

The FDA approved Symvess as a vascular conduit for extremity arterial injuries in adults when urgent revascularization is needed to avoid limb loss, and an autologous vein graft is not feasible, according to a press release.

The FDA has updated the definition of “healthy,” so food labels will have to abide by new rules to earn the title, according to a press release.

Adequate sleep was associated with a significantly reduced risk for hypertension among adolescents, independent of environmental noise exposure, according to findings published in the Journal of the American Heart Association.

The FDA approved Tryngolza for the treatment of adults with familial chylomicronemia syndrome when used in combination with an appropriate low-fat diet, according to an Ionis Pharmaceutical press release.

Men’s health has been declining for years in the United States, and health literacy may play an unexpectedly large role, according to experts.